Description
Recombinant monoclonal antibody to HLAII-DP. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma CBL 100 BRA FB6.
Target
HLAII-DP
Target Alias Names
HLA-DPB1, HLA-DP1B, MHC class II antigen DPB1, HLA class II histocompatibility antigen, DP(W4) beta chain, HLA class II histocompatibility antigen, DP beta 1 chain, MHC II, MHCII, BRA-FB6, BRAFB6
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression